Recent studies have shown the association between transmembrane protein 41A (TMEM41A) and the occurrences and developments of gastrointestinal tumors [6, 7], with significantly higher expression levels of SREBF pathway regulator in golgi 1 (SPRING1) in colorectal cancer than in adjacent normal tissues. This evidence concerns the gene SPRING1 and colorectal cancer.